Focus on bladder cancer
Top Cited Papers
- 1 August 2004
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 6 (2) , 111-116
- https://doi.org/10.1016/j.ccr.2004.08.002
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Correlation of Metastasis Related Gene Expression and Relapse-Free Survival in Patients With Locally Advanced Bladder Cancer Treated With Cystectomy and ChemotherapyJournal of Urology, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerNew England Journal of Medicine, 2003
- SALVAGE INTRAVESICAL THERAPY WITH INTERFERON-α2B PLUS LOW DOSE BACILLUS CALMETTE-GUERIN IS EFFECTIVE IN PATIENTS WITH SUPERFICIAL BLADDER CANCER IN WHOM BACILLUS CALMETTE-GUERIN ALONE PREVIOUSLY FAILEDJournal of Urology, 2001
- An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapiesCancer Gene Therapy, 2000
- Genetic studies and molecular markers of bladder cancerSeminars in Surgical Oncology, 1997
- The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year OutcomeJournal of Urology, 1997
- A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogeneNature, 1982
- Intravesical Bacillus Calmette-Guerin Versus Mitomycin C For Superficial Bladder Cancer: A Formal Meta-Analysis of Comparative Studies on Recurrence and ToxicityPublished by Wolters Kluwer Health